This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial

This study has been completed.
National Science Council, Taiwan
Taipei Hospital, Taiwan
Information provided by:
Taipei City Hospital Identifier:
First received: September 29, 2006
Last updated: August 31, 2009
Last verified: August 2009
The purpose of this study is to examine whether the extract of the green tea is effective on obese women.

Condition Intervention Phase
Obesity Drug: the extract of green tea Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial

Resource links provided by NLM:

Further study details as provided by Taipei City Hospital:

Primary Outcome Measures:
  • (Percent) reduction of body mass index and body weight

Secondary Outcome Measures:
  • (Percent) reduction of: Glucose, cholesterol,LDL, HDL and triglyceride
  • leptin, adiponectin and ghrelin comparisons and analysis

Estimated Enrollment: 100
Study Start Date: September 2006
Study Completion Date: June 2007
Detailed Description:
We conducted the pilot study in 2005. The initial findings showed the extract of green tea is benefit on obese women. The potential benefit include appetite lowing, lipid markers decreasing and regulating balance of obese related hormone peptides. So we designed this trial.

Ages Eligible for Study:   16 Years to 60 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. Age 16-60 years old female
  2. BMI>27㎞/m2
  3. Signed informed consent

Exclusion Criteria:

  1. Endocrine disease, e.g. thyroid disorder, pituitary disorder, and sex gland disorder.
  2. Heart disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker.
  3. Allergy and Immunology disease.
  4. High aminotransferases ( Alanine, Aspartate >80 IU/L) or high serum Creatinine (>2.5 mg/dL)
  5. Pregnant or lactating women.
  6. Childbirth within 6 months.
  7. Stroke or otherwise unable to exercise
  8. Management for weight control within 3 months.
  9. Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00383058

Taipei Hospital
Taipei, Taiwan, 886
Sponsors and Collaborators
Taipei City Hospital
National Science Council, Taiwan
Taipei Hospital, Taiwan
Study Director: Chung-Hua Hsu, MD, PhD Chinese Medicine Dep, Taipei Hospital
  More Information

Additional Information:
study  This link exits the site

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00383058     History of Changes
Other Study ID Numbers: TH-Greentea-06-01
Study First Received: September 29, 2006
Last Updated: August 31, 2009

Keywords provided by Taipei City Hospital:
green tea

Additional relevant MeSH terms:
Vision Disorders
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Eye Diseases
Signs and Symptoms processed this record on August 17, 2017